These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 27697585)
1. Human Herpesvirus 6 Infection Following Haploidentical Transplantation: Immune Recovery and Outcome. Greco R; Crucitti L; Noviello M; Racca S; Mannina D; Forcina A; Lorentino F; Valtolina V; Rolla S; Dvir R; Morelli M; Giglio F; Barbanti MC; Lupo Stanghellini MT; Oltolini C; Vago L; Scarpellini P; Assanelli A; Carrabba MG; Marktel S; Bernardi M; Corti C; Clementi M; Peccatori J; Bonini C; Ciceri F Biol Blood Marrow Transplant; 2016 Dec; 22(12):2250-2255. PubMed ID: 27697585 [TBL] [Abstract][Full Text] [Related]
2. Long-term prognosis of human herpesvirus 6 reactivation following allogeneic hematopoietic stem cell transplantation. Iesato K; Hori T; Yoto Y; Yamamoto M; Inazawa N; Kamo K; Ikeda H; Iyama S; Hatakeyama N; Iguchi A; Sugita J; Kobayashi R; Suzuki N; Tsutsumi H Pediatr Int; 2018 Jun; 60(6):547-552. PubMed ID: 29542206 [TBL] [Abstract][Full Text] [Related]
3. Human herpesvirus 6 reactivation in unmanipulated haploidentical hematopoietic stem cell transplantation predicts the occurrence of grade II to IV acute graft-versus-host disease. Han TT; Zhang YN; Sun YQ; Kong J; Wang FR; Wang ZD; Cheng YF; Yan CH; Wang Y; Xu LP; Zhang XH; Liu KY; Huang XJ; Zhao XS Transpl Infect Dis; 2021 Jun; 23(3):e13544. PubMed ID: 33326670 [TBL] [Abstract][Full Text] [Related]
6. Early human herpes virus type 6 reactivation in umbilical cord blood allogeneic stem cell transplantation. Cirrone F; Ippoliti C; Wang H; Zhou XK; Gergis U; Mayer S; Shore T; van Besien K Leuk Lymphoma; 2016 Nov; 57(11):2555-9. PubMed ID: 26984480 [TBL] [Abstract][Full Text] [Related]
7. Impact of Human Herpesvirus-6 Reactivation on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation. Aoki J; Numata A; Yamamoto E; Fujii E; Tanaka M; Kanamori H Biol Blood Marrow Transplant; 2015 Nov; 21(11):2017-22. PubMed ID: 26226409 [TBL] [Abstract][Full Text] [Related]
8. Comparative Outcomes after Haploidentical or Unrelated Donor Bone Marrow or Blood Stem Cell Transplantation in Adult Patients with Hematological Malignancies. Baker M; Wang H; Rowley SD; Cai L; Pecora AL; Skarbnik A; Vesole DH; Adler-Brecher B; Kim D; Donato ML Biol Blood Marrow Transplant; 2016 Nov; 22(11):2047-2055. PubMed ID: 27522040 [TBL] [Abstract][Full Text] [Related]
9. Human herpesvirus 6 encephalitis in patients administered mycophenolate mofetil as prophylaxis for graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Inui Y; Yakushijin K; Okamura A; Tanaka Y; Shinzato I; Nomura T; Ichikawa H; Mizutani Y; Kitao A; Kurata K; Kakiuchi S; Miyata Y; Sanada Y; Kitagawa K; Uryu K; Kawamoto S; Yamamoto K; Matsuoka H; Murayama T; Ito M; Minami H Transpl Infect Dis; 2019 Feb; 21(1):e13024. PubMed ID: 30414316 [TBL] [Abstract][Full Text] [Related]
10. The impact of human herpesvirus 6B reactivation on early complications following allogeneic hematopoietic stem cell transplantation. Wang LR; Dong LJ; Zhang MJ; Lu DP Biol Blood Marrow Transplant; 2006 Oct; 12(10):1031-7. PubMed ID: 17067909 [TBL] [Abstract][Full Text] [Related]
11. Early human herpesvirus type 6 reactivation after allogeneic stem cell transplantation: a large-scale clinical study. Dulery R; Salleron J; Dewilde A; Rossignol J; Boyle EM; Gay J; de Berranger E; Coiteux V; Jouet JP; Duhamel A; Yakoub-Agha I Biol Blood Marrow Transplant; 2012 Jul; 18(7):1080-9. PubMed ID: 22212513 [TBL] [Abstract][Full Text] [Related]
12. Reactivation of Human Herpes Virus-6 After Pediatric Stem Cell Transplantation: Risk Factors, Onset, Clinical Symptoms and Association With Severity of Acute Graft-Versus-Host Disease. Verhoeven DH; Claas EC; Jol-van der Zijde CM; Thijssen JC; Lankester AC; Bredius RG; Putter H; Kroes AC; Egeler RM; Schilham MW; van Tol MJ Pediatr Infect Dis J; 2015 Oct; 34(10):1118-27. PubMed ID: 26132825 [TBL] [Abstract][Full Text] [Related]
13. Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease. Gotoh M; Yoshizawa S; Katagiri S; Suguro T; Asano M; Kitahara T; Akahane D; Okabe S; Tauchi T; Ito Y; Ohyashiki K Transpl Infect Dis; 2014 Jun; 16(3):440-9. PubMed ID: 24810656 [TBL] [Abstract][Full Text] [Related]
14. The complex relationship between human herpesvirus 6 and acute graft-versus-host disease. Pichereau C; Desseaux K; Janin A; Scieux C; Peffault de Latour R; Xhaard A; Robin M; Ribaud P; Agbalika F; Chevret S; Socié G Biol Blood Marrow Transplant; 2012 Jan; 18(1):141-4. PubMed ID: 21801705 [TBL] [Abstract][Full Text] [Related]
15. Foscarnet against human herpesvirus (HHV)-6 reactivation after allo-SCT: breakthrough HHV-6 encephalitis following antiviral prophylaxis. Ogata M; Satou T; Inoue Y; Takano K; Ikebe T; Ando T; Ikewaki J; Kohno K; Nishida A; Saburi M; Miyazaki Y; Ohtsuka E; Saburi Y; Fukuda T; Kadota J Bone Marrow Transplant; 2013 Feb; 48(2):257-64. PubMed ID: 22750998 [TBL] [Abstract][Full Text] [Related]
16. High human herpesvirus 6 viral load in pediatric allogeneic hematopoietic stem cell transplant patients is associated with detection in end organs and high mortality. Winestone LE; Punn R; Tamaresis JS; Buckingham J; Pinsky BA; Waggoner JJ; Kharbanda S Pediatr Transplant; 2018 Mar; 22(2):. PubMed ID: 29181879 [TBL] [Abstract][Full Text] [Related]
17. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome. de Pagter PJ; Schuurman R; Visscher H; de Vos M; Bierings M; van Loon AM; Uiterwaal CS; van Baarle D; Sanders EA; Boelens J Biol Blood Marrow Transplant; 2008 Jul; 14(7):831-9. PubMed ID: 18541204 [TBL] [Abstract][Full Text] [Related]
18. Analysis of the shedding of three β-herpesviruses DNA in Polish patients subjected to allogeneic hematopoietic stem cell transplantation: Six-year follow up. Dzieciatkowski T; Tomaszewska A; Przybylski M; Rusicka P; Basak GW; Jedrzejczak WW; Wroblewska M; Halaburda K J Clin Virol; 2016 Mar; 76():30-5. PubMed ID: 26809130 [TBL] [Abstract][Full Text] [Related]
19. Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis. Hill JA; Koo S; Guzman Suarez BB; Ho VT; Cutler C; Koreth J; Armand P; Alyea EP; Baden LR; Antin JH; Soiffer RJ; Marty FM Biol Blood Marrow Transplant; 2012 Nov; 18(11):1638-48. PubMed ID: 22564265 [TBL] [Abstract][Full Text] [Related]
20. Low incidence of HHV-6 reactivation in haploidentical hematopoietic stem cell transplantation with corticosteroid as graft-vs-host disease prophylaxis compared with cord blood transplantation. Tamaki H; Ikegame K; Yoshihara S; Kaida K; Yoshihara K; Inoue T; Kato R; Nakata J; Fujioka T; Soma T; Okada M; Ogawa H Transpl Infect Dis; 2019 Jun; 21(3):e13073. PubMed ID: 30875143 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]